Rare diseases
Investigational molecules
Locations
Back to Germany3 clinical trials in Idar-Oberstein, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)GermanyGermanyGermanyThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking research focusing on Philadelphia-Chromosome positive acute lymphoblastic leukemia, evaluating innovative combination therapies including tyrosine kinase inhibitors and targeted treatments.
This study aims to advance treatment options for patients with specific genetic markers.
Investigation into advanced treatment protocols for Advanced Stage Hodgkin Lymphoma, comparing innovative therapeutic regimens to reduce treatment-related toxicity while maintaining efficacy.
The research focuses on optimizing treatment outcomes while minimizing side effects.
Advanced clinical investigation of high-risk Chronic Lymphocytic Leukemia, evaluating novel triple-combination therapy approaches for patients with specific genetic mutations.
This research aims to improve outcomes for patients with complex genetic profiles.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
